MGLL Antikörper
Kurzübersicht für MGLL Antikörper (ABIN2726234)
Target
Alle MGLL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens monoglyceride lipase (MGLL), transcript variant 1
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human MGLL (NP_009214) produced in HEK293T cell.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- WB 1:2000, IHC 1:150, IF 1:100, FLOW 1:100
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- MGLL (Monoglyceride Lipase (MGLL))
-
Andere Bezeichnung
- MGLL
-
Hintergrund
- Monoglyceride lipase (MGLL, EC 3.1.1.23) functions together with hormone-sensitive lipase (LIPE, MIM 151750) to hydrolyze intracellular triglyceride stores in adipocytes and other cells to fatty acids and glycerol. MGLL may also complement lipoprotein lipase (LPL, MIM 238600) in completing hydrolysis of monoglycerides resulting from degradation of lipoprotein triglycerides (Karlsson et al., 2001 [PubMed 11470505]).
-
Molekulargewicht
- 34.1 kDa
-
Gen-ID
- 11343
-
NCBI Accession
- NM_007283
-
HGNC
- 11343
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Lipid Metabolism
Target
-